Drug recall · January 28, 2026
Diclofenac Sodium Topical Gel recall
Why: Failed PH Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39
- Lots / codes
Batch XHBG; Exp. 08/31/2027
- Quantity
- 92,376 tubes
- Company
- Cipla USA, Inc., Warren, NJ
- Distribution
- Nationwide in the USA
- Initiated
- December 22, 2025 · Voluntary: Firm initiated
- Classified
- January 20, 2026
- Reported
- January 28, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diclofenac
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.